Rhythm Pharmaceuticals, Inc. (RYTM)
87.72
+0.91
(+1.05%)
USD |
NASDAQ |
Apr 14, 12:01
Rhythm Pharmaceuticals Cash from Investing (TTM) : -137.15M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Aldeyra Therapeutics, Inc. | 47.74M |
| Eli Lilly & Co. | -10.97B |
| Merck & Co., Inc. | -13.74B |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| MannKind Corp. | -304.80M |